Horizon Therapeutics Public Ltd Co
HZNPDelisted Oct 6, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001492426
Horizon Therapeutics Public Ltd Co was delisted on Oct 6, 2023; its insiders filed their last Form 4 on Oct 6, 2023; 483 institutions reported holding it in 13F filings for Q3 2023, worth $24.8B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q4 2022
Institutional positions in Horizon Therapeutics Public Ltd Co as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 611
- +91 vs. Q3 2022
- Shares held
- 208.8M
- −721.1K (−0.3%) vs. Q3 2022
- Total value
- $23.8B
- +$10.8B (+83.1%) vs. Q3 2022
- New holders
- 186
- 130 more added
- Sold out
- 95
- 240 more reduced
8 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HZNP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $116 |
| Q1 2026 | 1 | $116 |
| Q4 2025 | 1 | $116 |
| Q3 2025 | 1 | $116 |
| Q2 2025 | 1 | $116 |
| Q1 2025 | 1 | $116 |
| Q4 2024 | 1 | $116 |
| Q3 2024 | 1 | $116 |
| Q2 2024 | 2 | $3.95K |
| Q1 2024 | 1 | $116 |
| Q4 2023 | 6 | $49.4K |
| Q3 2023 | 483 | $24.8B |
| Q2 2023 | 516 | $21.7B |
| Q1 2023 | 552 | $22.5B |
| Q4 2022 | 611 | $23.8B |
| Q3 2022 | 528 | $13.0B |
| Q2 2022 | 615 | $16.5B |
| Q1 2022 | 618 | $21.8B |
| Q4 2021 | 609 | $22.0B |
| Q3 2021 | 571 | $22.2B |
| Q2 2021 | 527 | $18.9B |
| Q1 2021 | 516 | $18.4B |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Horizon Therapeutics Public Ltd Co; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wolff Wiese Magana LLC | 0 | $0 | 0.00% | −85−100.0% | Sold out |
| Ancora Advisors, LLC | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Almanack Investment Partners, LLC. | 0 | $0 | 0.00% | −26−100.0% | Sold out |
| Moisand Fitzgerald Tamayo, LLC | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| CVA Family Office, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Oliver Lagore Vanvalin Investment Group | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Jefferies Group LLC | – | – | – | – | Not filed |
| Eaton Vance Management | – | – | – | – | Not filed |
| American Portfolios Advisors | – | – | – | – | Not filed |
| Balasa Dinverno & Foltz LLC | – | – | – | – | Not filed |
| Redpoint Investment Management Pty Ltd | – | – | – | – | Not filed |
| Corient Capital Partners, LLC | – | – | – | – | Not filed |
| Wipfli Financial Advisors LLC, | – | – | – | – | Not filed |
| FourThought Financial, LLC | – | – | – | – | Not filed |